Neurokinin A and the neurohypophysial response to melatonin: In vitro studies

Journal of Physiology and Pharmacology

Volumn 53, Issue 4 II, 2002, Pages 823-834

  Juszczak, Marlena ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Melatonin; Neurokinin A; Oxytocin; Vasopressin

Indexed keywords

MELATONIN; NEUROKININ A; OXYTOCIN; PINEAL BODY HORMONE; POTASSIUM CHANNEL; VASOPRESSIN;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EVOKED RESPONSE; HORMONE RELEASE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IN VITRO STUDY; INHIBITION KINETICS; MALE; NONHUMAN; OXYTOCIN RELEASE; RADIOIMMUNOASSAY; RAT; SUPRACHIASMATIC NUCLEUS; VASOPRESSIN RELEASE;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MELATONIN; NEUROKININ A; ORGAN CULTURE TECHNIQUES; OXYTOCIN; POTASSIUM; RATS; RATS, WISTAR; VASOPRESSINS;

EID: 0036912719     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Robinson AG, Roberts MM, Wayne AE, Janocko LE, Hoffman GE. Total translation of vasopressin and oxytocin in neurohypophysis of rats. Am J Physiol 1989; 257: R109-R117.
2. Juszczak M. Melatonin affects the oxytocin and prolactin responses to stress in male rats. J Physiol Pharmacol 1998; 49: 151-163.
3. Juszczak M, Guzek JW, Lewy A. The influence of melatonin on the content of vasopressin and oxytocin in the hypothalamus and neurohypophysis in euhydrated and dehydrated male rats. J Pineal Res 1986; 3: 199-211.
4. Juszczak M, Stempniak B. The effect of melatonin on suckling-induced oxytocin and prolactin release in the rat. Brain Res Bull 1997; 44: 253-258.
5. Juszczak M, Debeljuk L, Stempniak B, Steger RW, Fadden C, Bartke A. Neurohypophyseal vasopressin in the Syrian hamster: Response to short photoperiod, pinealectomy, melatonin treatment or osmotic stimulation. Brain Res Bull 1997; 42: 221-225.
6. Juszczak M, Steger RW, Debeljuk L et al. The effects of short photoperiod, pinealectomy and melatonin treatment on oxytocin synthesis and release in the male Syrian hamster. Endocrine 1996; 4: 223-231.
7. Juszczak M, Steger RW, Fadden C, Bartke A. Oxytocin and prolactin release after hypertonic saline administration in melatonin-treated male Syrian hamsters. J Physiol Pharmacol 1996; 47: 289-301.
8. Lipińska S. The role of adrenoceptors in the regulation of oxytocin and vasopressin release after superior cervical ganglionectomy. J Physiol Pharmacol 2000; 51: 111-125.
9. Larsen PJ, Jukes KE, Chowdrey HS, Lightman SL, Jessop DS. Neuropeptide-Y potentiates the secretion of vasopressin from the neurointermediate lobe of the rat pituitary gland. Endocrinology 1994; 134: 1635-1639.
10. Chowdrey HS, Lightman SL. Role of central amino acids and peptide-mediated pathways in neurohypophysial hormone release. Ann NY Acad Sci 1993; 689: 183-193.
11. Bojanowska E, Stempniak B. TGLP-1 and release of vasopressin and oxytocin from the isolated rat hypothalamo-neurohypophysial system: Effects of a TGLP-1 receptor agonist and antagonist. J Physiol Pharmacol 2001; 52: 781-793.
12. Ciosek J, Guzek JW, Orłowska-Majdak M. Thyrotropin-releasing hormone (TRH) modulates vasopressin and oxytocin release from the hypothalamo-neurohypophysial system in dehydrated rats. J Physiol Pharmacol 1993; 44: 293-302.
13. Bojanowska E, Guzek JW, Da̧browski R. Luteinizing hormone-releasing hormone and function of the magnocellular vasopressinergic system. Neuropeptides 1999; 33: 301-305.
14. Maggio J. Tachykinins. Ann Rev Neurosci 1988; 11: 13-28.
15. Torrens Y, Beaujouan J-C, Dietl M, Saffroy M, Petitet F, Glowinski J. Tachykinin receptors: Binding and cellular activity assays. Methods Neurosci 1991; 5: 243-267.
16. Kato Y, Chihara K, Ohgo S, Iwasaki Y, Abe H, Immura H. Growth hormone and prolactin release by substance P in rats. Life Sci 1976; 19: 441-446.
17. Pisera D, Debeljuk L, Seilicovich A et al. Possible role of neurokinin A in the control of prolactin secretion in rats and hamsters. J Neuroendocrinol 1991; 3: 39-44.
18. Debeljuk L, Lasaga M. Modulation of the hypothalamo-pituitary-gonadal axis and the pineal gland by neurokinin A, neuropeptide K and neuropeptide γ. Peptides 1999; 20: 285-299.
19. Arisawa M, Snyder G, McCann S. Effects of substance P on thyrotropin secretion from the pituitary gland in the rat. Peptides 1989; 10: 763-766.
20. Chowdrey HS, Jessop DS, Lightman SL, Substance P stimulates arginine vasopressin and inhibits adrenocorticotropin release in vivo in the rat. Neuroendocrinology 1990; 52: 90-93.
21. Hatae T, Kawano H, Karpitskiy V, Krause JE, Masuko S. Arginine-vasopressin neurons in the rat hypothalamus produce neurokinin B and co-express the tachykinin NK-3 receptor and angiotensin II type I receptor. Arch Histol Cytol 2001; 64: 37-44.
22. Jessop DS, Chowdrey HS, Lightman SL. Substance P and substance K in the median eminence and paraventricular nucleus of the rat hypothalamus. Neuropeptides 1990; 17: 135-140.
23. Larsen PJ, Jessop DS, Chowdrey HS, Mikkelsen JD, Lightman SL. Osmotic regulation of substance P and neurokinin A peptide content and substance P binding sites in distinct hypothalamic nuclei of the rat. Peptides 1992; 13: 705-712.
24. Debeljuk L, Bartke A. Immunoreactive substance P and neurokinin A in the hypothalamus and anterior pituitary gland of Siberian and Syrian hamsters and of rats. J Reprod Fertil 1994; 101: 427-434.
25. Mikkelsen JD, Larsen PJ, Moller M, Vilhardt H, Sarmark T. Substance P in the median eminence and pituitary of the rat: Demonstration of immunoreactive fibers and specific binding sites. Neuroendocrinology 1989; 50: 100-108.
26. Duval P, Lenoir V, Moussaoui S, Garret C, Kerdelhue B. Substance P and neurokinin A variations throughout the rat oestrous cycle; comparison with ovariectomized and male rats: I. Plasma, hypothalamus, anterior and posterior pituitary. J Neurosci Res 1996; 45: 598-609.
27. Bojanowska E, Forsling ML. The effects of melatonin on vasopressin secretion in vivo: Interactions with acetylcholine and prostaglandins. Brain Res Bull 1997; 42: 457-461.
28. Juszczak M, Debeljuk L, Bartke A, Stempniak B. Melatonin inhibits oxytocin and vasopressin release from the neurointermediate lobe of the hamster pituitary. Neuroreport 1995; 6: 2453-2456.
29. Juszczak M, Stempniak B, Guzek JW. Melatonin, pinealectomy and release of neurohypophysial hormones: In vitro studies. J Pineal Res 1992; 12: 1-6.
30. Yasin SA, Costa A, Besser GM, Hucks D, Grossman A, Forsling ML. Melatonin and its analogs inhibit the basal and stimulated release of hypothalamic vasopressin and oxytocin in vitro. Endocrinology 1993; 132: 1329-1336.
31. Yasin SA, Grossman A, Forsling ML. Diurnal variation in the effect of melatonin on neurohypophysial hormone release from the rat hypothalamus. Brain Res Bull 1996; 39: 1-5.
32. Yasin SA, Forsling ML. Mechanisms of melatonin inhibition of neurohypophysial hormone release from the rat hypothalamus in vitro. Brain Res Bull 1998; 45: 53-59.
33. De Laurentiis A, Pisera D, Duvilanski B, Rettori V, Lasaga M, Seilicovich A. Neurokinin A inhibits oxytocin and GABA release from the posterior pituitary by stimulating nitric oxide synthase. Brain Res Bull 2000; 53: 325-330.
34. Gregg CM, Sladek CD. A compartmentalized, organ-culture hypothalamo-neurohypophysial system for the study of vasopressin release. Neuroendocrinology 1984; 38: 397-402.
35. Verbalis JG, Baldwin EF, Ronnekleiv OK, Robinson AG. In vitro release of vasopressin and oxytocin from rat median eminence tissue. Neuroendocrinology 1986; 42: 481-488.
36. Massi M, Polidori C, Perfumi M, Gentili L, De Caro G. Tachykinin receptor subtypes involved in the central effects of tachykinins on water and salt intake. Brain Res Bull 1991; 26: 155-160.
37. Kadowaki K, Kishimoto J, Leng G, Emson PC. Up-regulation of nitric oxide synthase (NOS) gene expression together with NOS activity in the rat hypothalamo-hypophysial system after chronic salt loading: Evidence of a neuromodulatory role of nitric oxide in arginine vasopressin and oxytocin secretion. Endocrinology 1994; 143: 1011-1017.
38. Williams LM, Hannah LT, Hasting MH, Maywood ES. Melatonin receptors in the rat brain and pituitary. J Pineal Res 1995; 19: 173-177.
39. Hermes MLHJ, Coderre EM, Buijs RM, Renaud LP, GABA and glutamate mediate rapid neurotransmission from suprachiasmatic nucleus to hypothalamic paraventricular nucleus in rat. J Physiol 1996; 496: 749-757.
40. Cui LN, Saeb-Parsy K, Dyball REJ. Neurons in the supraoptic nucleus of the rat are regulated by a projection from the suprachiasmatic nucleus. J Physiol 1997; 502: 149-159.
41. Alexiuk NAM, Vriend JP. Melatonin reduces dopamine content in the neurointermediate lobe of male Syrian hamsters. Brain Res Bull 1993; 32: 433-436.
42. Alexiuk NAM, Uddin M, Vriend JP. Melatonin increases the in situ activity of tyrosine hydroxylase in the mediobasal hypothalamus of male Syrian hamsters. Life Sci 1996; 59: 687-694.
43. Vanecek J, Watanabe K. Mechanisms of melatonin action in the pituitary and SCN. Adv Exp Med Biol 1999; 460: 191-198.
44. Isobe Y, Torii T, Nishino H. Melatonin inhibits Arg-vasopressin release via MT2 receptor in the suprachiasmatic nucleus-slice culture of rats. Brain Res 2001; 889: 214-219.
45. Reiter RJ, Oh C-S, Fujimori O. Melatonin: Its intracellular and genomic actions. Trends Endocrinol Metab 1996; 7: 22-27.